- This difference-in-differences study of 1,663,441 US singleton deliveries from 2013 to 2024 used Epic Cosmos data, comparing cesarean with vaginal births.
- The exposure was the period after publication of the 2016 azithromycin trial, compared with the period before it, rather than direct drug assignment.
- Perioperative azithromycin use in cesarean births rose by an adjusted 37.6 percentage points (95% CI, 33.1 to 42.2), reaching 39.6% after 2016.
- Postpartum infection after cesarean fell by an adjusted 2.0 percentage points (95% CI, -2.6 to -1.4), and the authors link this to wider azithromycin adoption.
Obstetric
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.